Thrombospondin-1 Expression in Epithelial Ovarian Carcinoma: Association with p53 Status, Tumor Angiogenesis, and Survival in Platinum-Treated Patients

By Alvarez A.A.   Axelrod J.R.   Whitaker R.S.   Isner P.D.   Bentley R.C.   Dodge R.K.   Rodriguez G.C.  

Gynecologic Oncology, Vol. 82, Iss. 2, 2001-08 ,pp. : 273-278

Elsevier

Access to resources Recommend Favorite

Detection of the TP53 Tumour Suppressor Gene Product and p53 Auto-antibodies in the Ascites of Women with Ovarian Cancer

By Angelopoulou K.   Diamandis E.P.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite

Loss of Expression of the p16 Tumor Suppressor Gene Is More Frequent in Advanced Ovarian Cancers Lacking p53 Mutations

By Havrilesky L.J.   Alvarez A.A.   Whitaker R.S.   Marks J.R.   Berchuck A.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 491-500

Elsevier

Access to resources Recommend Favorite

Expression of p53 Protein as a Prognostic Factor in Patients With Gastric Cancer

By Victorzon M.   Nordling S.   Haglund C.   Lundin J.   Roberts P.J.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 215-220

Elsevier

Access to resources Recommend Favorite

Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression - a review of the evidence

By Downing S.R.   Jackson P.   Russell P.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 3, 2001-05 ,pp. : 103-110

Elsevier

Access to resources Recommend Favorite